Grant: CIHR Fellowship
Direct Payment
$150,000.00
Comparative Effectiveness of Drugs Using Electronic Health Records from Canada, US and the UK.
EF 2011-12
Résumé
Prescription drugs play a rapidly expanding and important role in the prevention and treatment of common health problems. Over 60% of adult Canadians have used at least one prescription drug in the past 6 months, and six or more drugs are taken by 18% of the older population. While there are considerable benefits from modern drug therapy, the frequent occurrence of adverse drug-related events and the uncertainty about effects of drugs after they enter the market have highlighted fundamental shortcomings in the ability to actively monitor drugs after their approval.
Electronic health records, computerized prescribing and automated patient follow-up systems are health information technologies that are being increasingly used to improve the quality of care around the world. These new health information technologies provide an unprecedented opportunity to develop an active surveillance system that will monitor and provide patients and physicians with real-time feedback on the comparative safety and effectiveness of new drugs.
Conducting active surveillance on a collaborative international scale will provide more rapid information about drug safety and effectiveness from users around the world as well as permit more personalized risk/benefit analysis for subgroups where drugs may have a different risk/benefit profile.
The purpose of this project is to develop state-of-the-art methods of i) monitoring, and ii) analyzing the comparative risk and benefit of new drug therapies, in real-time, through an international prospective surveillance system.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
242795
Name
Eguale Tewodros
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training B - HP
Projecttitle
Comparative Effectiveness of Drugs Using Electronic Health Records from Canada, US and the UK.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adverse Drug Reactions; Comparative Effectiveness; Compouterized Decision Support; Computerized Prescribing; Electronic Health Record; Evidence-Based Prescribing; Indication-Based Prescribing; Patient Safety; Pharmacoepidemiology; Pharmacosurveillance
Abstract
Prescription drugs play a rapidly expanding and important role in the prevention and treatment of common health problems. Over 60% of adult Canadians have used at least one prescription drug in the past 6 months, and six or more drugs are taken by 18% of the older population. While there are considerable benefits from modern drug therapy, the frequent occurrence of adverse drug-related events and the uncertainty about effects of drugs after they enter the market have highlighted fundamental shortcomings in the ability to actively monitor drugs after their approval.
Electronic health records, computerized prescribing and automated patient follow-up systems are health information technologies that are being increasingly used to improve the quality of care around the world. These new health information technologies provide an unprecedented opportunity to develop an active surveillance system that will monitor and provide patients and physicians with real-time feedback on the comparative safety and effectiveness of new drugs.
Conducting active surveillance on a collaborative international scale will provide more rapid information about drug safety and effectiveness from users around the world as well as permit more personalized risk/benefit analysis for subgroups where drugs may have a different risk/benefit profile.
The purpose of this project is to develop state-of-the-art methods of i) monitoring, and ii) analyzing the comparative risk and benefit of new drug therapies, in real-time, through an international prospective surveillance system.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Eguale, Tewodros
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~